Targeting mTOR in renal cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting mTOR in renal cell carcinoma

Published:2009-04-28 Issue:S10 Volume:115 Page:2313-2320
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hudes Gary R.¹

Affiliation:

1. Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Funder

Genentech, Novartis Pharmaceuticals, Pfizer, Inc., and Wyeth Pharmaceuticals

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.24239

Reference48 articles.

1. Activation of AKT Kinases in Cancer: Implications for Therapeutic Targeting

2. The Biology and Clinical Relevance of the PTEN Tumor Suppressor Pathway

3. ATM and related protein kinases: safeguarding genome integrity

4. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression

5. Immunophilins, mTOR, and pharmacodynamic strategies for a targeted cancer therapy;Harding MW;Clin Cancer Res.,2003

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

2. Enhancing autophagy in Alzheimer's disease through drug repositioning;Pharmacology & Therapeutics;2022-09

3. Characterization and function of biomarkers in sunitinib-resistant renal carcinoma cells;GENE;2022

4. Characterization and function of biomarkers in sunitinib-resistant renal carcinoma cells;Gene;2022-07

5. Playing the Devil’s Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors;Cancer Management and Research;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3